High dupilumab levels in tear fluid of atopic dermatitis patients with moderate‐to‐severe ocular surface disease

Overview of attention for article published in Clinical and Translational Allergy, January 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

news: 2 news outlets

twitter: 8 X users

Citations

dimensions_citation: 4 Dimensions

Readers on

mendeley: 9 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 2 news stories from 2 outlets.

Dupilumab levels high in tears of patients with moderate to severe ocular surface disease

Healio.com, 20 Feb 2023

Patients with atopic dermatitis and moderate to severe ocular surface disease who were treated with dupilumab had higher levels…

Higher Dupilumab Levels in Tear Fluid for Atopic Dermatitis Patients with Ocular Surface Disease

HCP Live, 24 Jan 2023

Roselie Achten In a recent study from the Netherlands, atopic dermatitis (AD) patients with moderate-to-severe ocular surface…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.